Atossa Therapeutics
ATOS
#9337
Rank
HK$0.71 B
Marketcap
HK$5.56
Share price
-13.37%
Change (1 day)
-33.18%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -HK$1.95

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$1.94. In 2024 the company made an earnings per share (EPS) of -HK$1.56 an increase over its 2023 EPS that were of -HK$1.87.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$1.9525.32%
2024-HK$1.56-16.67%
2023-HK$1.8714.29%
2022-HK$1.6316.67%
2021-HK$1.40-90.86%
2020-HK$15.32-2.96%
2019-HK$15.79-63.09%
2018-HK$42.78-49.63%
2017-HK$84.94-57.87%
2016-HK$201.62-74.01%
2015-HK$775.68-9.18%
2014-HK$854.08-12.86%
2013-HK$980.0970.73%
2012-HK$574.0534.08%
2011-HK$428.15263.47%
2010-HK$117.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.20-4,275.76%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$79.73-4,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$67.21-3,556.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$1.63-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-HK$6.85 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA